Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-10-057548)

Filing Details

Accession Number:: 0001181431-10-057548
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-24 12:36:42
Reporting Period:: 2010-11-23

Filing Date:: 2010-11-24
Accepted Time:: 2010-11-24 12:36:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1356857	Trius Therapeutics Inc	TSRX	Pharmaceutical Preparations (2834)	201320630

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1120362	F Paul Truex	C/O Trius Therapeutics, Inc. 6310 Nancy Ridge Drive, Suite 101 San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-11-23	7,364	$1.29	10,270	No	4	M	Direct
Common Stock	Acquisiton	2010-11-23	1,000	$3.50	11,270	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2010-11-23	7,364	$0.00	7,364	$1.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,403		2018-05-20	No	4	M	Direct

Footnotes

In accordance with its terms, the option is immediately exercisable in full; however, the shares underlying the option are subject to vesting. As of the date of this Form 4, 12,766 shares are fully vested, with the remaining 7,001 shares vesting monthly through April 1, 2012.